Di-Chimeric Cell Therapy Derived From Hematopoietic and Mesenchymal Stem Cells Promotes Immune Tolerance and Extends Vascularized Composite Allograft Survival
Authors
Maria Siemionow
Department of Orthopaedics, University of Illinois at Chicago, Chicago, USA
Safak Halil Uygur
Department of Orthopaedics, University of Illinois at Chicago, Chicago, USA
Katarzyna Stawarz
Department of Orthopaedics, University of Illinois at Chicago, Chicago, USA
Lucile Chambily
Department of Orthopaedics, University of Illinois at Chicago, Chicago, USA
Katarzyna Budzynska
Department of Orthopaedics, University of Illinois at Chicago, Chicago, USA
Weronika Radecka
Department of Orthopaedics, University of Illinois at Chicago, Chicago, USA
DOI: https://doi.org/10.2478/aite-2026-0013 | Journal eISSN: 1661-4917
Language: English
Submitted on: Dec 19, 2025
Accepted on: Feb 23, 2026
Published on: Apr 9, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2026 Maria Siemionow, Safak Halil Uygur, Katarzyna Stawarz, Lucile Chambily, Katarzyna Budzynska, Weronika Radecka, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.